“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk.

The New York Times is soliciting readers’ questions about the dangers — and benefits — posed by artificial intelligence.

The technology is far from the only existential risk our species faces. But weighing such cosmic fears can become a mind-bending exercise.

A controversy around OpenAI’s latest math proof raises a fear that might become increasingly common: that A.I. tools could take valuable insights from one user and hand them to another.

OpenAI announced today that it had solved the problem, one of seven “Millennium Problems” seen as among the most important in higher mathematics.

The company’s announcement is the most dramatic sign yet that artificial intelligence is fundamentally transforming the field of higher mathematics.

Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.